Bank of Montreal
HUMA icon

Bank of Montreal’s Humacyte HUMA Stock Holding History

Bank of Montreal’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-98,601
Closed -$495K – 4017
2024
Q2 		$495K Buy
+98,601
New +$513K ﹤0.01% 2409

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's HUMA Position: Q3 2024 in Review

Bank of Montreal sold out of Humacyte (HUMA) in Q3 2024, closing a stake of 98,601 shares — an estimated $495K sold.

Bank of Montreal first reported a position in HUMA in Q2 2024 and held it in 1 quarter. The position peaked at $495K in Q2 2024. 143 funds tracked by Wall St. Rank hold HUMA as of Q3 2024.

  • Bank of Montreal reported no remaining Humacyte position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 98,601 Humacyte shares in Q3 2024, an estimated $495K.
  • Bank of Montreal first reported a position in Humacyte in Q2 2024 and held it in 1 quarter.
  • Bank of Montreal's Humacyte position peaked at $495K in Q2 2024.
  • 143 funds tracked by Wall St. Rank held Humacyte as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.